In part 2 of our podcast, our experts discuss how companies can move beyond information overload to build true #CompetitiveReadiness through focus, collaboration, and action. Tune in: buff.ly/Hoblg2Q
#LaunchReadiness #LaunchExcellence #CompetitiveStrategy #Pharma #Biotech

In a crowded healthcare market, simply having data is no longer enough. Tune into the podcast to learn how to transform information into insights and insights into real competitive advantage! buff.ly/htwkckB
#LaunchReadiness #CompetitiveIntelligence #ClinicalData #LaunchExcellence #ClinicalInsights

Our latest #MedicalAffairs podcast addresses how early #MedAffairs engagement—through narrative, site relationships, integrated #Evidence, and #HEOR—can accelerate trials and strengthen #LaunchReadiness. Listen here: buff.ly/rS0CC1O

How Novo Nordisk misread the US market for its weight loss sensation Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the Danish drugmaker in a more vulnerable position when rival Eli Lilly entered the market, six former employees involved in the discussions told Reuters.

#NovoNordisk #weightloss #Wegovy #launchreadiness #pricingstrategy #weightlossdrug #EliLilly #pharmaceuticalsupply #pharmaceuticalforecasting #launchpreparedness #pharmaceuticaldemand #pharmaceutcalsupplyshortages #Wegovysupplyissues #volumecappedlaunches
www.reuters.com/sustainabili...

The first full issue of Medical Affairs Pulse is out now! Download the issue at buff.ly/QTn5wP6 or browse the flipbook edition at buff.ly/maBsCjt

#MedicalAffairs #MedicalAffairsUnscripted #MedAffairs #StakeholderEngagement #LaunchReadiness #MedicalAffairsPodcast